739 related articles for article (PubMed ID: 31622538)
1. Fecal microbiota transplantation results in bacterial strain displacement in patients with inflammatory bowel diseases.
Zou M; Jie Z; Cui B; Wang H; Feng Q; Zou Y; Zhang X; Yang H; Wang J; Zhang F; Jia H
FEBS Open Bio; 2020 Jan; 10(1):41-55. PubMed ID: 31622538
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
[TBL] [Abstract][Full Text] [Related]
4. A Matching Strategy To Guide Donor Selection for Ulcerative Colitis in Fecal Microbiota Transplantation: Meta-Analysis and Analytic Hierarchy Process.
Zhang B; Yang L; Ning H; Cao M; Chen Z; Chen Q; Lian G; Tang H; Wang Q; Wang J; Lin Z; Wen J; Liu Y; Xuan J; Li X; Lin A; He J; Zhang L; Hou X; Zeng Q; Xiao C
Microbiol Spectr; 2023 Feb; 11(1):e0215921. PubMed ID: 36472435
[TBL] [Abstract][Full Text] [Related]
5. The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation.
He R; Li P; Wang J; Cui B; Zhang F; Zhao F
Gut Microbes; 2022; 14(1):2100197. PubMed ID: 35854629
[TBL] [Abstract][Full Text] [Related]
6. Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease.
Goyal A; Yeh A; Bush BR; Firek BA; Siebold LM; Rogers MB; Kufen AD; Morowitz MJ
Inflamm Bowel Dis; 2018 Jan; 24(2):410-421. PubMed ID: 29361092
[TBL] [Abstract][Full Text] [Related]
7. A Two-Week Fecal Microbiota Transplantation Course in Pediatric Patients with Inflammatory Bowel Disease.
Karolewska-Bochenek K; Grzesiowski P; Banaszkiewicz A; Gawronska A; Kotowska M; Dziekiewicz M; Albrecht P; Radzikowski A; Lazowska-Przeorek I
Adv Exp Med Biol; 2018; 1047():81-87. PubMed ID: 29151253
[TBL] [Abstract][Full Text] [Related]
8. Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.
Paramsothy S; Nielsen S; Kamm MA; Deshpande NP; Faith JJ; Clemente JC; Paramsothy R; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Lin E; Borody TJ; Wilkins MR; Colombel JF; Mitchell HM; Kaakoush NO
Gastroenterology; 2019 Apr; 156(5):1440-1454.e2. PubMed ID: 30529583
[TBL] [Abstract][Full Text] [Related]
9. Specific fungi associated with response to capsulized fecal microbiota transplantation in patients with active ulcerative colitis.
Chen Q; Fan Y; Zhang B; Yan C; Chen Z; Wang L; Hu Y; Huang Q; Su J; Ren J; Xu H
Front Cell Infect Microbiol; 2022; 12():1086885. PubMed ID: 36683707
[TBL] [Abstract][Full Text] [Related]
10. Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results.
Cui B; Feng Q; Wang H; Wang M; Peng Z; Li P; Huang G; Liu Z; Wu P; Fan Z; Ji G; Wang X; Wu K; Fan D; Zhang F
J Gastroenterol Hepatol; 2015 Jan; 30(1):51-8. PubMed ID: 25168749
[TBL] [Abstract][Full Text] [Related]
11. Increased Intestinal Microbial Diversity Following Fecal Microbiota Transplant for Active Crohn's Disease.
Vaughn BP; Vatanen T; Allegretti JR; Bai A; Xavier RJ; Korzenik J; Gevers D; Ting A; Robson SC; Moss AC
Inflamm Bowel Dis; 2016 Sep; 22(9):2182-90. PubMed ID: 27542133
[TBL] [Abstract][Full Text] [Related]
12. Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesity.
Wilson BC; Vatanen T; Jayasinghe TN; Leong KSW; Derraik JGB; Albert BB; Chiavaroli V; Svirskis DM; Beck KL; Conlon CA; Jiang Y; Schierding W; Holland DJ; Cutfield WS; O'Sullivan JM
Microbiome; 2021 May; 9(1):107. PubMed ID: 33985595
[TBL] [Abstract][Full Text] [Related]
13. Metagenomic and bile acid metabolomic analysis of fecal microbiota transplantation for recurrent Clostridiodes difficile and/or inflammatory bowel diseases.
Ramos RJ; Zhu C; Joseph DF; Thaker S; Lacomb JF; Markarian K; Lee HJ; Petrov JC; Monzur F; Buscaglia JM; Chawla A; Small-Harary L; Gathungu G; Morganstern JA; Yang J; Li J; Pamer EG; Robertson CE; Frank DN; Cross JR; Li E
Med Res Arch; 2022 Oct; 10(10):. PubMed ID: 36618438
[TBL] [Abstract][Full Text] [Related]
14. Fecal Microbiota Transplantation in Experimental Ulcerative Colitis Reveals Associated Gut Microbial and Host Metabolic Reprogramming.
Yan ZX; Gao XJ; Li T; Wei B; Wang PP; Yang Y; Yan R
Appl Environ Microbiol; 2018 Jul; 84(14):. PubMed ID: 29728388
[TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy and safety of monotherapy with a single fresh fecal microbiota transplant for recurrent active ulcerative colitis: a prospective randomized pilot study.
Fang H; Fu L; Li X; Lu C; Su Y; Xiong K; Zhang L
Microb Cell Fact; 2021 Jan; 20(1):18. PubMed ID: 33468164
[TBL] [Abstract][Full Text] [Related]
16. Dynamic Colonization of Microbes and Their Functions after Fecal Microbiota Transplantation for Inflammatory Bowel Disease.
Chu ND; Crothers JW; Nguyen LTT; Kearney SM; Smith MB; Kassam Z; Collins C; Xavier R; Moses PL; Alm EJ
mBio; 2021 Aug; 12(4):e0097521. PubMed ID: 34281401
[TBL] [Abstract][Full Text] [Related]
17. Siderophore-harboring gut bacteria and fecal siderophore genes for predicting the responsiveness of fecal microbiota transplantation for active ulcerative colitis.
Yan J; Zhou G; Ren R; Zhang X; Zhang N; Wang Z; Peng L; Yang Y
J Transl Med; 2024 Jun; 22(1):589. PubMed ID: 38915068
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiome, metabolome, host immunity associated with inflammatory bowel disease and intervention of fecal microbiota transplantation.
Wu R; Xiong R; Li Y; Chen J; Yan R
J Autoimmun; 2023 Dec; 141():103062. PubMed ID: 37246133
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy analysis of fecal microbiota transplantation in the treatment of 2010 patients with intestinal disorders].
Li N; Tian HL; Chen QY; Yang B; Ma CL; Lin ZL; Zhang XY; Zhao D; Huang ZX; Jiang J; Qin HL
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):861-868. PubMed ID: 31550826
[No Abstract] [Full Text] [Related]
20. The Microbial Composition of Bacteroidetes Species in Ulcerative Colitis Is Effectively Improved by Combination Therapy With Fecal Microbiota Transplantation and Antibiotics.
Ishikawa D; Sasaki T; Takahashi M; Kuwahara-Arai K; Haga K; Ito S; Okahara K; Nakajima A; Shibuya T; Osada T; Hiramatsu K; Watanabe S; Nagahara A
Inflamm Bowel Dis; 2018 Nov; 24(12):2590-2598. PubMed ID: 30124831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
